These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 33298341)
1. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry. Arjona-Sanchez A; Aziz O; Passot G; Salti G; Esquivel J; Van der Speeten K; Piso P; Nedelcut DS; Sommariva A; Yonemura Y; Turaga K; Selvasekar CR; Rodriguez-Ortiz L; Sanchez-Hidalgo JM; Casado-Adam A; Rufian-Peña S; Briceño J; Glehen O Eur J Surg Oncol; 2021 Jun; 47(6):1420-1426. PubMed ID: 33298341 [TBL] [Abstract][Full Text] [Related]
2. Long-term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low-grade pseudomyxoma peritonei and multicystic mesothelioma. Mercier F; Jeremie G; Alyami M; Delphine V; Vahan K; Pascal R; Sylvie I; Guillaume P; Olivier G Surg Endosc; 2020 Nov; 34(11):4916-4923. PubMed ID: 31792692 [TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study. Di Leo A; Corvasce A; Weindelmayer J; Mason EJ; Casella F; de Manzoni G Updates Surg; 2020 Dec; 72(4):1207-1212. PubMed ID: 32410159 [TBL] [Abstract][Full Text] [Related]
4. Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center. Li XB; Ma R; Ji ZH; Lin YL; Zhang J; Yang ZR; Chen LF; Yan FC; Li Y Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):600-606. PubMed ID: 31973925 [TBL] [Abstract][Full Text] [Related]
5. The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery. Kusamura S; Barretta F; Yonemura Y; Sugarbaker PH; Moran BJ; Levine EA; Goere D; Baratti D; Nizri E; Morris DL; Glehen O; Sardi A; Barrios P; Quénet F; Villeneuve L; Gómez-Portilla A; de Hingh I; Ceelen W; Pelz JOW; Piso P; González-Moreno S; Van Der Speeten K; Deraco M; JAMA Surg; 2021 Mar; 156(3):e206363. PubMed ID: 33502455 [TBL] [Abstract][Full Text] [Related]
6. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies. Passot G; Bakrin N; Isaac S; Decullier E; Gilly FN; Glehen O; Cotte E Eur J Surg Oncol; 2014 Aug; 40(8):957-62. PubMed ID: 24209429 [TBL] [Abstract][Full Text] [Related]
7. Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients. Ji ZH; Yu Y; Liu G; Zhang YB; An SL; Li B; Li XB; Yan GJ; Li Y Eur J Surg Oncol; 2021 Jun; 47(6):1411-1419. PubMed ID: 33293213 [TBL] [Abstract][Full Text] [Related]
8. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Long term oncologic outcomes from the international PSOGI registry. Arjona-Sanchez A; Aziz O; Passot G; Salti G; Serrano A; Esquivel J; Van der Speeten K; Sommariva A; Kazi M; Shariff U; Martínez-Regueira F; Piso P; Yonemura Y; Turaga K; Sgarbura O; Avanish Saklani A; Tonello M; Rodriguez-Ortiz L; Vazquez-Borrego MC; Romero-Ruiz A; Glehen O; Eur J Surg Oncol; 2023 Oct; 49(10):107001. PubMed ID: 37579618 [TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience. Iversen LH; Rasmussen PC; Hagemann-Madsen R; Laurberg S Colorectal Dis; 2013 Jul; 15(7):e365-72. PubMed ID: 23458368 [TBL] [Abstract][Full Text] [Related]
10. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution. Tabrizian P; Shrager B; Jibara G; Yang MJ; Romanoff A; Hiotis S; Sarpel U; Labow DM J Gastrointest Surg; 2014 May; 18(5):1024-31. PubMed ID: 24577736 [TBL] [Abstract][Full Text] [Related]
11. Clinico-pathological outcomes after total parietal peritonectomy, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced serous papillary peritoneal carcinoma submitted to neoadjuvant systemic chemotherapy- largest single institute experience. Deraco M; Sinukumar S; Salcedo-Hernández RA; Rajendra VJ; Baratti D; Guaglio M; Nizri E; Kusamura S Eur J Surg Oncol; 2019 Nov; 45(11):2103-2108. PubMed ID: 31230982 [TBL] [Abstract][Full Text] [Related]
12. A comprehensive review of childbearing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Papageorgiou D; Manatakis DK; Papakonstantinou K; Kyriazanos ID Arch Gynecol Obstet; 2020 Oct; 302(4):793-799. PubMed ID: 32653946 [TBL] [Abstract][Full Text] [Related]
13. Iterative procedures combining cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for isolated peritoneal recurrence. Vaira M; Robella M; Mellano A; Sottile A; De Simone M Int J Hyperthermia; 2014 Dec; 30(8):565-9. PubMed ID: 25430988 [TBL] [Abstract][Full Text] [Related]
14. Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Birgisson H; Enblad M; Artursson S; Ghanipour L; Cashin P; Graf W Eur J Surg Oncol; 2020 Dec; 46(12):2283-2291. PubMed ID: 32873455 [TBL] [Abstract][Full Text] [Related]
15. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results. Golse N; Bakrin N; Passot G; Mohamed F; Vaudoyer D; Gilly FN; Glehen O; Cotte E J Surg Oncol; 2012 Aug; 106(2):197-203. PubMed ID: 22331814 [TBL] [Abstract][Full Text] [Related]
17. Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry. Votanopoulos KI; Sugarbaker P; Deraco M; Morris D; Glehen O; Elias D; De Simone M; Robella M; Heyd B; Kusamura S; Baratti D; Chouliaras K; Russell G; Shen P; Levine EA; Ann Surg Oncol; 2018 Mar; 25(3):667-673. PubMed ID: 29260418 [TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study. Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674 [TBL] [Abstract][Full Text] [Related]
19. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: morbidity and postoperative outcomes. Robella M; Vaira M; Cinquegrana A; De Simone M Minerva Chir; 2019 Jun; 74(3):195-202. PubMed ID: 29589675 [TBL] [Abstract][Full Text] [Related]
20. Critical Analysis of Stage IV Epithelial Ovarian Cancer Patients after Treatment with Neoadjuvant Chemotherapy followed by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC). Munoz-Zuluaga CA; Sardi A; Sittig M; Gushchin V; King MC; Nieroda C; Lopez-Ramirez F; Diaz-Montes TP Int J Surg Oncol; 2020; 2020():1467403. PubMed ID: 33381312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]